Introdução: A relevância clínica da presença de anticorpos anti-HLA após o transplante renal tem sido foco de recente atenção para os estudiosos da histocompatibilidade. Pacientes que possuem anticorpos anti-HLA no póstransplante apresentam maior incidência de rejeição aguda (RA) e de nefropatia crônica do enxerto (NCE). Como conseqüência, alguns perdem o órgão transplantado ou sofrem com as reações imunopatológicas correspondentes. Entretanto, existem algumas controvérsias sobre o grau de valorização da presença desses anticorpos na etiopatogenia da RA e da NCE, pois nem todos os pacientes com anticorpos evoluem mal. Objetivo: Avaliar a presença de anticorpos anti-HLA no primeiro ano do transplante renal e verificar sua associação com a ocorrência de RA e NCE. Pacientes e Método: Este estudo incluiu consecutivamente 88 pacientes submetidos a transplante renal no Serviço de Nefrologia do Hospital de Clínicas de Porto Alegre, entre outubro de 2002 a outubro de 2004. Amostras de sangue foram colhidas no 1º, 3º, 6º e 12º meses pós-transplante renal, visando à pesquisa de anticorpos IgG anti-HLA de classes I e II. Nos pacientes que consentiram, biópsias renais de protocolo foram realizadas entre o 2º e o 3º mês e no 12º mês póstransplante. A detecção dos anticorpos foi realizada através de ensaio ELISA (LATM e LAT-1240, One Lambda Inc., USA). Rejeição aguda e a NCE foram diagnosticadas por critérios clínicos, laboratoriais e histopatológicos. Resultados: Oitenta e oito pacientes foram avaliados, sendo 40 (45,5%) do sexo feminino e setenta e dois (81,8%) de etnia caucasóide. Setenta e um (80,6%) receberam rins de doador falecido. Foi detectada a presença de anticorpos anti-HLA em vinte pacientes (22,7%). Desses, somente 3 (4,4%) desenvolveram anticorpos anti-HLA (classe I) no período pós-transplante; os demais (17) já os apresentavam no período prétransplante. No seguimento até um ano, 23 pacientes (26,1%) apresentaram RA e 43 (51,2%) desenvolveram NCE. Nove (45%) pacientes com anticorpos no póstransplante desenvolveram RA contra 14 (20,6%) dos sem anticorpos (P=0,058). Entre os pacientes com anticorpos no pós-transplante, 11 (64,7%) desenvolveram NCE contra 32 (47,8%) dos sem anticorpos (P=0,329). Na análise histológica, os anticorpos anti-HLA foram associados à RA IIA (P=0,001) e à NCE grau II (P= 0,012). As variáveis preditoras para a RA e NCE foram, respectivamente, presença de anticorpos anti-HLA de classe I no 1º mês pós-transplante (OR= 4,30; IC 95%= 1,32-14,1; P= 0,016) e transplante com órgão de doador-limítrofe (OR= 4,81; IC 95%= 1,18-20,3; P= 0,028). Setenta por cento (70%) dos pacientes com RA desenvolveram NCE, contra 45,3% dos pacientes sem RA (P= 0,054). Conclusão: Os anticorpos anti-HLA presentes no primeiro ano do transplante renal foram associados a RA e NCE. A pesquisa de anticorpos anti-HLA no pós-transplante renal realizada por outros pesquisadores e aqui também avaliada, se adotada como rotina, possibilitaria a identificação de casos de mau prognóstico e a escolha de planos terapêuticos mais adequados. A correlação entre anticorpos anti-HLA e rejeição deverá se tornar mais evidente com o passar dos anos, sendo que nossos resultados fortalecem a convicção da necessidade de continuidade desses estudos. / Introduction: The clinical relevance of the presence of anti-HLA antibodies following kidney transplant has been the recent focus of attention of histocompatibility researchers. Patients who present anti-HLA antibodies in the post-transplant period have shown higher incidence of acute rejection (AR) and of chronic allograft nephropathy (CAN). As a result, some lose the transplanted organ or suffer from the corresponding immunopathological reactions. However, there has been some controversy as to the importance of the presence of these antibodies in the ethiopathology of AR and CAN, since not all patients who have these antibodies present the same outcome. Objective: To evaluate the presence of anti-HLA antibodies during the first year of kidney transplantation and to check its association with the occurrence of AR and CAN. Patients and Method: This research included consecutively 88 patients who had undergone kidney transplants in the Hospital de Clínicas de Porto Alegre Nephrology Service between October 2002 and October 2004. Blood samples were taken during the 1st, 3rd, 6th and 12th months post kidney transplant, aiming at researching for Class I and II IgG anti-HLA antibodies. In consenting patients, protocol kidney biopsies were carried out between the 2nd and 3rd months and in the 12th month after the transplant. Detection of antibodies was done through ELISA test (LAT-M and LAT-1240, One Lambda Inc., USA). Acute rejection and CAN were diagnosed through clinical, laboratorial and histopathological criteria. Results: Eighty-eight patients were evaluated, among which 40 (45.5%) were female and seventy-two (81.8%) were Caucasian. Seventy-one (80.6%) received kidneys from deceased donors. The presence of anti-HLA antibodies was found in 20 patients (22.7%). Among these, only 3 (4.4%) developed anti-HLA antibodies (class I) during the post-transplant period; the remaining (17) already presented these antibodies during the pre-transplant period. In the follow-up up to one year, 23 patients (26.1%) presented AR and 43 (51.2%) developed CAN. Nine patients (45%) with antibodies in the post-transplant period developed AR as opposed to 14 (20.6%) patients without antibodies (P=0.058). Among the patients with antibodies in the post-transplant period, 11 (64.7%) developed CAN as opposed to 32 (47.8%) of those without antibodies (P=0.329). In the histological analysis, the anti-HLA antibodies were associated to AR IIA (P=0.001) and to CAN degree II (P= 0.012). The predictive variables for AR and CAN were, respectively, the presence of Class I anti-HLA antibodies in the first month post-transplant (OR= 4.30; IC 95%= 1.32-14.1; P= 0.016) and transplant with expanded criteria donors (OR= 4.81; IC 95%= 1.18-20.3; P= 0.028). Seventy per cent of the patients presenting AR developed CAN, as opposed to 45.3% of the patients without AR (P= 0.054). Conclusion: The anti-HLA antibodies present in the first year of the kidney transplant were associated to AR and CAN. The research of anti-HLA antibodies in the kidney post-transplant period carried by other researchers, as well as in this study, if done routinely, would allow the identification of cases with a poor prognosis and the choice of more adequate treatments. The correlation of anti-HLA antibodies and rejection will become more evident with time, and our results reinforce the certainty that these studies must continue.
| Identifer | oai:union.ndltd.org:IBICT/oai:lume56.ufrgs.br:10183/8732 |
| Date | January 2007 |
| Creators | Toresan, Realdete |
| Contributors | Jobim, Luiz Fernando Job, Manfro, Roberto Ceratti |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis |
| Format | application/pdf |
| Source | reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, instname:Universidade Federal do Rio Grande do Sul, instacron:UFRGS |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.003 seconds